De Europese Commissie heeft 24 projecten geselecteerd waarmee nieuwe programma s zullen worden opgezet, of bestaande worden uitgebreid, voor de inzameling …
We have seen it all. From arguments against Covid-19 restrictions as unconstitutional and paternalistic to the global corruption that was associated with the distribution of personal protective equipment (PPE).
We have also heard prominent jurists and judges across many jurisdictions talking about the Covid-19 issues. Notable for me, as a legal scholar, is the rather unusual critique of the Covid-19 lockdowns by the US Supreme Court Justice Samuel A Alito Jr in a reported speech to a conservative legal group, drawing a rebuke from other judges. And Alito Jr might be compromising his opportunity to sit on the Bench when lockdown-related cases come to the Supreme Court.
EU Reporter
Employment: Coronavirus crisis hits young people and low-paid workers in particular, shows Employment and Social Development Quarterly Review
Published 3 months ago
The European Commission has published the December 2020 edition of the Employment and Social Developments Quarterly Review, analysing the effects of the coronavirus pandemic on jobs and incomes. It shows that policy measures cushioned the impact of the coronavirus crisis, with employment falling less than GDP and unemployment remaining stable over the past months. Nonetheless, challenges remain. The impact of the crisis on young people is very serious, and unemployment may well rise over the next few months.
Introduction
In contrast to the United Kingdom, which approved its first COVID-19 vaccine on 2 December 2020 and subsequently began administering it on 8 December 2020, Belgium is following the lead of the European Commission and the European Medicines Agency (EMA) with respect to its COVID-19 vaccine strategy. The European Commission, on behalf of EU member states, has already concluded six advance purchase agreements with vaccine suppliers for a potential total of almost 2 billion doses. Belgium s share presently amounts to a total of 22.4 million vaccines. Purchasing and administering the first vaccine will kick off in the 2020 Christmas holiday period, given that the first vaccine was only very recently demonstrated to be safe and effective and was granted a conditional marketing authorisation by the European Commission.